As prolonged drug treatment will probably be needed to keep IGF1 levels sufficiently low to prevent tumor reappearance or to target longevity, BM001 will be a useful tool to investigate the ancillary factors that affect IGF1 levels. This evidence concerns the gene IGF1 and neoplasm.